An investment manager with a analytical mind, she began seeking information to better understand her potentially life-altering condition. I was also inundated with relatives and friends coming out with crackpot therapies — and even from other patients in chemo wards and waiting rooms. As a cancer researcher deeply involved in science outreach, I can attest that few subjects provoke quite the emotional response that cancer does.
Skip Navigation. Breast cancer can be a scary topic for women. For many, even getting an annual breast cancer screening can be an unsettling experience.
Nominate your favorite video by emailing us at nominations healthline. According to the American Cancer Societyapproximatelycases of invasive breast cancer and 63, cases of noninvasive breast cancer will be diagnosed in women this year. Adriana Lopez, as she battles breast cancer.
With tears in her eyes, Peggy Kessler recalls her victory over stage 4 pancreatic cancer. This type of ad is not an anomaly. A report out this week from TruthInAdvertising. But of the 43 institutions examined by TINA.
Share this video on your social channels, and double-up by sending it around to your team as well. A win for your business and breast cancer awareness. Get your audience buzzing with a short video celebrating everyone's favorite morning brew.
Genomic Health does not give treatment for cancer or advise patients on their treatment plans. Anyone in doubt about their own health or cancer should seek medical advice from a qualified healthcare professional. As the only test proven to predict chemotherapy benefit, the Oncotype DX test is included in all major cancer guidelines worldwide and now considered as standard of care for women with early-stage breast cancer with unprecedented prospective patient outcomes in more than 63, patients from four large, independently run, international studies.
Skip to Content. Erica Mayer discusses what is important for patients to know about early stage breast cancer following a diagnosis. Beginning with types of breast cancer, Dr. Mayer guides patients through understanding their treatment plan and health care team, recent advancements in research and treatments, and questions to ask.
Most of these multimedia assets are in the public domain, may be used free of charge for any educational or non-commercial purpose, and cannot be copyrighted. The videos may also be viewed on NCI websites. Publicly available cancer-related photographs and biomedical illustrations may be downloaded from NCI Visuals Online.
KISQALI is indicated for the treatment of women with hormone receptor HR —positive, human epidermal growth factor receptor 2 HER2 —negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. How can your first-line treatment decision make all the difference? References: 1. Data on file.